Effect of PEA-OXA on neuropathic pain and functional recovery after sciatic nerve crush

[1]  J. Howard,et al.  IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration , 2018, The Journal of Immunology.

[2]  S. Cuzzocrea,et al.  Anti‐inflammatory effect of ATB‐352, a H2S −releasing ketoprofen derivative, on lipopolysaccharide‐induced periodontitis in rats , 2017, Pharmacological research.

[3]  S. Cuzzocrea,et al.  2-Pentadecyl-2-Oxazoline, the Oxazoline of Pea, Modulates Carrageenan-Induced Acute Inflammation , 2017, Front. Pharmacol..

[4]  S. Cuzzocrea,et al.  Beneficial Effects of Co‐Ultramicronized Palmitoylethanolamide/Luteolin in a Mouse Model of Autism and in a Case Report of Autism , 2017, CNS neuroscience & therapeutics.

[5]  S. Cuzzocrea,et al.  Traumatic Brain Injury Leads to Development of Parkinson's Disease Related Pathology in Mice , 2016, Front. Neurosci..

[6]  S. Cuzzocrea,et al.  2-pentadecyl-2-oxazoline: Identification in coffee, synthesis and activity in a rat model of carrageenan-induced hindpaw inflammation. , 2016, Pharmacological research.

[7]  F. Caraci,et al.  A Link Between Nerve Growth Factor Metabolic Deregulation and Amyloid-β-Driven Inflammation in Down Syndrome. , 2016, CNS & neurological disorders drug targets.

[8]  Jian-Wei Zhu,et al.  Toll-Like Receptor 4 Deficiency Impairs Motor Coordination , 2016, Front. Neurosci..

[9]  Hangdi Xu,et al.  Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation , 2015, Molecular medicine reports.

[10]  D. J. Kopsky,et al.  Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome , 2015, Journal of pain research.

[11]  E. Kuyucu,et al.  Effect of oxytocin administration on nerve recovery in the rat sciatic nerve damage model , 2015, Journal of Orthopaedic Surgery and Research.

[12]  D. Lin,et al.  Potential analgesic effects of a novel N-acylethanolamine acid amidase inhibitor F96 through PPAR-α , 2015, Scientific Reports.

[13]  A. Usiello,et al.  Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice , 2015, Molecular Brain.

[14]  S. Cuzzocrea,et al.  N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution , 2015, Molecular Neurobiology.

[15]  S. Cuzzocrea,et al.  Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity , 2015, PloS one.

[16]  Maree T. Smith,et al.  Neurotrophins and Neuropathic Pain: Role in Pathobiology , 2015, Molecules.

[17]  P. Magistretti,et al.  Deficiency in monocarboxylate transporter 1 (MCT1) in mice delays regeneration of peripheral nerves following sciatic nerve crush , 2015, Experimental Neurology.

[18]  Wei Cheng,et al.  Spinal NF-κB and Chemokine Ligand 5 Expression during Spinal Glial Cell Activation in a Neuropathic Pain Model , 2015, PloS one.

[19]  Haitham Khraishah,et al.  (-)-Epigallocatechin-3-gallate modulates spinal cord neuronal degeneration by enhancing growth-associated protein 43, B-cell lymphoma 2, and decreasing B-cell lymphoma 2-associated x protein expression after sciatic nerve crush injury. , 2015, Journal of neurotrauma.

[20]  Teng Zhang,et al.  Edaravone promotes functional recovery after mechanical peripheral nerve injury , 2014, Neural regeneration research.

[21]  Shigeharu Suzuki,et al.  The Changes of c-Fos Expression by Motor Cortex Stimulation in the Deafferentation Pain Model , 2014, Neurologia medico-chirurgica.

[22]  M. Philipp,et al.  Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain , 2013, Mediators of inflammation.

[23]  D. Bennett,et al.  Neuroinflammation and the generation of neuropathic pain. , 2013, British journal of anaesthesia.

[24]  M. Slezak,et al.  Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism , 2013, PloS one.

[25]  R. Bertorelli,et al.  Antinociceptive effects of the N-acylethanolamine acid amidase inhibitor ARN077 in rodent pain models , 2013, PAIN®.

[26]  H. Tozaki-Saitoh,et al.  Microglial regulation of neuropathic pain. , 2013, Journal of pharmacological sciences.

[27]  S. Skaper,et al.  Palmitoylethanolamide: biochemistry, pharmacology and therapeutic use of a pleiotropic anti-inflammatory lipid mediator. , 2013, CNS & neurological disorders drug targets.

[28]  S. Cuzzocrea,et al.  Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma. , 2013, Mini reviews in medicinal chemistry.

[29]  Masato Ogata,et al.  Critical role of p38 MAPK for regeneration of the sciatic nerve following crush injury in vivo , 2013, Journal of Neuroinflammation.

[30]  P. Tak,et al.  The resolution of inflammation , 2012, Nature Reviews Immunology.

[31]  L. Dahlin,et al.  Expression of Activating Transcription Factor 3 (ATF 3) and caspase 3 in Schwann cells and axonal outgrowth after sciatic nerve repair in diabetic BB rats , 2012, Neuroscience Letters.

[32]  E. Masliah,et al.  Autophagy is increased in postmortem brains of persons with HIV-1-associated encephalitis. , 2011, The Journal of infectious diseases.

[33]  Sevki Sahin,et al.  [Electrophysiologic and histopathologic evaluation of peripheral nerve regeneration at different nerve segments and with different repair techniques]. , 2008, Acta orthopaedica et traumatologica turcica.

[34]  N. Takezaki,et al.  The N‐Acylethanolamine‐Hydrolyzing Acid Amidase (NAAA) , 2007, Chemistry & biodiversity.

[35]  K. Campbell,et al.  Attenuated pain responses in mice lacking CaV3.2 T‐type channels , 2007, Genes, brain, and behavior.

[36]  P. Pacher,et al.  The Endocannabinoid System as an Emerging Target of Pharmacotherapy , 2006, Pharmacological Reviews.

[37]  D. Tracey,et al.  Immune and inflammatory mechanisms in neuropathic pain , 2006, Brain Research Reviews.

[38]  D. Wright,et al.  Modulation of muscle spindle innervation by neurotrophin-3 following nerve injury , 2005, Experimental Neurology.

[39]  A. Koeppen,et al.  Wallerian degeneration: history and clinical significance , 2004, Journal of the Neurological Sciences.

[40]  D. Tracey,et al.  Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells , 2003, Pain.

[41]  L. Parada,et al.  Brain remodeling due to neuronal and astrocytic proliferation after controlled cortical injury in mice , 2001, Journal of neuroscience research.

[42]  R. Raffa,et al.  Antihistamines as analgesics , 2001, Journal of clinical pharmacy and therapeutics.

[43]  M. D. Taylor, R. Vancura, J. M. Williams, J. T. Riekh.  Overexpression of neurotrophin-3 in skeletal muscle alters normal and injury-induced limb control , 2001 .

[44]  C. Woolf,et al.  Changes in tactile stimuli‐induced behavior and c‐Fos expression in the superficial dorsal horn and in parabrachial nuclei after sciatic nerve crush , 2000, The Journal of comparative neurology.

[45]  O. Gureje,et al.  Persistent pain and well-being: a World Health Organization Study in Primary Care. , 1998, JAMA.

[46]  P. Moskowitz,et al.  Sensory neurons selectively upregulate synthesis and transport of the beta III-tubulin protein during axonal regeneration , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[47]  K. Sharkey,et al.  Accumulation and degranulation of mast cells in experimental neuromas , 1994, Neuroscience Letters.

[48]  R. Dubner,et al.  A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia , 1987, Pain.

[49]  T. Nakagawa,et al.  Spinal astrocytes as therapeutic targets for pathological pain. , 2010, Journal of pharmacological sciences.

[50]  Stefano Geuna,et al.  Chapter 4: Methods and protocols in peripheral nerve regeneration experimental research: part I-experimental models. , 2009, International review of neurobiology.

[51]  J. Bienenstock,et al.  Mast cells , 2004, Springer Seminars in Immunopathology.

[52]  S. Mackinnon,et al.  Functional recovery and histomorphometric assessment following tibial nerve injury in the mouse. , 2003, Journal of reconstructive microsurgery.

[53]  D. Metcalfe,et al.  Mast cells. , 1997, Physiological reviews.

[54]  A. Frankfurter,et al.  Expression of the class III β‐tubulin gene during axonal regeneration of rat dorsal root ganglion neurons , 1993 .